| Symbol | PTHS |
|---|---|
| Name | PELTHOS THERAPEUTICS INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 4020 STIRRUP CREEK DRIVE, DURHAM, NC 27703 |
| Telephone | 919-908-2422 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001919246 |
| Description | None |
New Form DEFA14A - Pelthos Therapeutics Inc. <b>Filed:</b> 2026-08-18 <b>AccNo:</b> 0001919246-26-000121 <b>Size:</b> 374 KB
Read moreNew Form DEF 14A - Pelthos Therapeutics Inc. <b>Filed:</b> 2026-08-18 <b>AccNo:</b> 0001919246-26-000120 <b>Size:</b> 1 MB
Read moreNew Form PRE 14A - Pelthos Therapeutics Inc. <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0001919246-26-000105 <b>Size:</b> 1 MB
Read morePelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
Read moreDirector Friedberg Ezra M 🔴 sold 558 shares of Pelthos Therapeutics Inc. (PTHS) at $27.33 Transaction Date: Jul 02, 2026 | Filing ID: 000102
Read moreDirector Pauls Matthew 🔴 sold 786 shares of Pelthos Therapeutics Inc. (PTHS) at $27.36 Transaction Date: Jul 02, 2026 | Filing ID: 000101
Read moreDirector Greenleaf Peter 🔴 sold 797 shares of Pelthos Therapeutics Inc. (PTHS) at $27.27 Transaction Date: Jul 02, 2026 | Filing ID: 000100
Read morePelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
Read more